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Background: Hypnotherapy has proved to be effective for the treatment of several medical and 
psychiatric conditions. It has been used in the treatment of alcohol use disorder (AUD), but only two 
randomized controlled trials have been conducted for this disorder.  
Methods: This study was carried out at an inpatient clinic in Norway. A six-week long treatment 
programme included intensive group therapy, but also five hours of individual therapy, given as 
motivational interviewing (MI). Thirty-one patients were randomized either to receive five individual 
sessions of hypnotherapy instead of MI (N=16) or to be in the control group (N=15). The treatment 
method for the hypnotherapy group was Erickson`s (permissive) hypnosis. At baseline all the 
participants were diagnosed using a psychiatric interview and filled in the Alcohol Use Identification 
Test (AUDIT), Timeline FollowBack (TLFB) for alcohol use, Hopkins Symptoms Check List (HSCL-25) for 
monitoring mental distress and Traumatic Life Events Questionnaire. AUDIT, TLFB and HSCL-25 were 
re-administered at follow-up after one year.  
Results: There were no differences between groups at baseline. One year later more women were 
lost to follow-up in the MI group. Both the intervention and control groups had reduced their alcohol 
consumption significantly. The change in AUDIT score was, however, largest for the hypnotherapy 
group, albeit only on a trend level (p=0.088). 
Conclusion: Those receiving hypnotherapy did marginally better concerning alcohol use at one-year 
follow-up. This small advantage for hypnotherapy could indicate an effect, rendered non-significant 
by an underpowered study. It could also be that neither MI nor hypnotherapy gave an additional 
effect on top of the substantial group therapy. Lastly the findings could indicate that hypnotherapy is 








Alcohol use causes around three percent of potential years of life lost and the same proportion of all 
deaths worldwide (Rehm and Shield, 2013). It was behind 85 million disability-adjusted years of life in 
2015 (GBD 2015 Risk Factors Collaborators, 2016). The annual toll of alcohol use disorders (AUD) is 
high worldwide (Welton and Higginson, 2012).  
There are effective psychological (Morgenstern and Longabaugh, 2000) and pharmacological (Anton 
et al., 2014) treatments for AUD. The measurable effects of these are, however, often small (Cutler 
and Fishbain, 2005, Jonas et al., 2014). No significant differences have been found between different 
psychological treatments (Cutler and Fishbain, 2005), but adding psychological treatment to a 
pharmacological intervention may have some advantages (Moyers et al., 2016). There is a debate 
about the importance of longer duration of counselling. On one hand, it has only been shown to 
provide a small additional effect (Kaner et al., 2018), but on the other hand, it has been 
demonstrated that the stability of remission is positively correlated with the length and intensity of 
treatment (Mertens et al., 2012). Recent studies demonstrated that mindfulness-based treatments 
can improve the stability of remission (Cavicchioli et al., 2018). Research into AUD treatment is 
difficult to evaluate because, despite its chronic course with frequent relapses, AUD can also have 
spontaneous remissions (Trim et al., 2013, Vaillant, 1996, Vaillant, 2003). The cumulative lifelong 
chance of experiencing a spontaneous remission of AUD is 90%, but as many as 50% of these 
remissions may end in a relapse (Lopez-Quintero et al., 2011).  
Hypnotherapy entails using hypnosis for therapeutic purposes. Hypnosis may involve changes in 
subjective experience, for example, reduction in self-orientation and an illusion of automaticity 
(Rainville and Price, 2003). These phenomena may be connected to changes in focused attention, 
changes that can even be demonstrated objectively either by EEG (Rainville and Price, 2003) or fMRI 
(Walsh et al., 2017). There are two styles of hypnotherapy: an authoritative style, where the patients 
passively receive hypnotic suggestions, and a permissive style, where the patients participate more 
actively in the therapeutic process (Erickson, 1998). The two styles may be combined.   
Hypnotherapy has proved to be effective in the treatment of chronic pain (Adachi et al., 2014), in 
adults undergoing medical or surgical procedure (Tefikow et al., 2013), in chronic headaches (Melis 
et al., 1991, Kohen, 2010), migraine (Anderson et al., 1975), fibromyalgia (Zech et al., 2017, Picard et 
al., 2013), Irritable Bowel Syndrome (IBS) (Webb et al., 2007), in recurrent abdominal pain in 
childhood (Abbott et al., 2017) and several other conditions. Impressive results were achieved by 
abreactive ego state therapy, a 5-6 hour long manualised hypnotherapy, in the treatment of PTSD 
(Barabasz et al., 2013). A single intervention resulted in an immediate significant reduction in PTSD 
check list (PCL) score. The patients maintained the treatment effect 18 weeks later. 
Many hynotherapists, including Milton Erickson himself, used hypnotherapy in treatment of AUD. 
Some publications describe the treatment without empirical data (Tramontana, 2009, Muezzinoglu, 
2009), but scientific publications are rare. We have identified only six scientific publications, based on 
empirical data. A case report for the treatment of AUD also reported success (Orman, 1991). Two 
open, non-controlled studies using so-called hypnoanalysis (Hartman, 1976) and Erikson’s hypnosis 
(Potter, 2004) reported 90% and 67% abstinence rate at follow-up, respectively. Two studies have 
been published on so-called hypno-aversion. The goal of this treatment was to make patients find 
alcohol repulsive. An open, non-controlled study found an abstinence rate of 62% at one year follow 
up (Miller, 1976). A controlled study using hypno-aversion as add on found no additional effect of the 
this treatment (Edwards, 1966).  
The most recent and well-designed study included three control groups: attention-placebo (stress 
management), cognitive-behavioural trans-theoretical intervention and no additional intervention 
group (Pekala et al., 2004). The abstinence rate in all groups was between 85 and 90% at two-month 
follow-up. However, the individuals in the self-hypnosis group, who played their audiotapes at least 3 
times a week, reported higher levels of self-esteem and serenity, and lower levels of 
anger/impulsivity, in comparison to the minimal-practice and control groups.  
The aim of this study was to investigate the effect of hypnotherapy for patients with AUD in a 
randomized controlled clinical trial.  
2. Methods 
This study was designed as a parallel study, where two groups were compared: one receiving 
treatment as usual (motivational interviewing; MI) and the intervention (hypnotherapy group). If the 
mean difference in treatment effect was as great as 40% we would have needed 46 participants to 
achieve statistical power (p=0.05). We had initially planned to recruit as many as 50 individuals, but 
many were sceptical to the novel treatment. Four persons withdrew from the hypnotherapy group 
either before or after first treatment because of uncertainty. This did not affect randomization and 
they are not represented in the results.  
Participants in the study were recruited from patients admitted to a six week long inpatient 
treatment programme at Vangseter Clinic in Norway in 2016. Only individuals who diagnosed with 
AUD were included in the study. The treatment programme consisted of the following elements:  5 
hours of group therapy 5 days a week, a 2-3 days long family visit, where a family therapy session 
was also included, some obligatory group activities, like trips to museums or walks in nature, and 
lastly, informal activities, such as barbecues, watching movies together or discussions in the hall. All 
this was thought to contribute to the therapy of the patients. From the second week of the 
programme the patients were expected to have one hour of additional individual therapy a week. It 
was conducted as MI, totalling five hours. MI is one of the most popular and effective modern 
treatments. As a brief intervention, MI appears to be at least as effective as, and possibly more 
effective than, other treatment methods (Kohler and Hofmann, 2015). As an alternative to the MI 
sessions half of the patients enrolled in the study could receive five individual hour-long sessions of 
hypnotherapy. These patients continued as the intervention group. 
Patients were informed about the study, were given time to consider, and if they volunteered to 
participate then signed a consent form. Thirty-one individuals took part in this randomized controlled 
trial (RCT). A list of numbers generated by www.randomiser.org was used for randomization. Patients 
were assigned numbers from the list in the order, in which they enlisted themselves into the study. 
The ones who received odd numbers were assigned to the hypnotherapy group (N=16), while the 
ones with even numbers became control group receiving MI (N=15). 
At the beginning of the second week of treatment (baseline) all the participants were administered 
MINI psychiatric interview to be able to diagnose mental problems other than AUD (Sheehan et al., 
1998). Exclusion criteria were having psychotic episodes, a recent severe other psychiatric diagnosis 
or recent drug abuse other than alcohol.  
In addition, all patients filled in the Alcohol Use Identification Test (AUDIT) and a Timeline Follow-
back (TLFB) for registration of number of standardized alcohol units consumed and alcohol-related 
problems during the previous month. They also filled in the Hopkins Symptoms Check List (HSCL-25) 
to measure their level of mental distress. Mental distress was given as a global average of the HSCL-
25 denoted Global Severity Index (GSI). The Traumatic Life Events Questionnaire was used to register 
traumatic life experiences. AUDIT, TLFB and HSCL-25 were re-administered one year later as a follow-
up. 
The intervention consisted of hypnotherapy given as five one-hour sessions over 5 weeks as 
individual therapy instead of motivational interviewing. The treatment method was Erickson`s 
(permissive) hypnosis (Erickson, 1998). Each treatment session began with a conversation about the 
patient`s past life events, present situation, alcohol problem and his or her thoughts about it. To be 
able to use visualisation, patients were always asked when and where they bought alcohol, and how 
it was consumed. During the first part of the treatment session the theme of the hypnotic 
intervention was formulated, and then hypnotic trance was induced. The induction method was 
mostly a combination of relaxation and breathing exercises with mental pictures of a peaceful place. 
Once the trance was induced, the patient was asked to visualize mastery of a selected situation. This 
situation was tailored according to the patient`s needs. It could include, for example, abstaining from 
alcohol at a party, passing an alcohol shop without going inside, or mastering another problematic 
issue, such as staying relaxed and calm in the presence of other people. When indicated, the events 
of the past were a subject of hypnotic intervention as well. 
Data were analysed using SPSS (IBM statistics) version 25, using simple bivariate analysis (Student’s 
T-test or chi-square test), comparing the intervention group and the control group. Level of 
significance was set to p < 0.05, but even higher values were considered as the risk of type II 
statistical errors would be substantial in the small randomized controlled trial.   
3. Results 
Table 1 shows that there were no group differences between those who were randomized to the 
experimental hypnotherapy group or the MI control group. This included gender, age, trauma 
experiences, diagnosis, and severity of AUD and symptoms of mental distress. There was a non-
significant tendency for the hypnotherapy group to have a higher AUDIT score (p=0.270). 
After one year we were able to follow-up with fewer women in the motivational interviewing group 
(tab. 2), making the gender distribution in the groups different. Both the intervention and control 
groups had reduced their alcohol consumption significantly; the control group had a reduction of 296 
units in the previous month (95 % CI 186-406 units last month), while the intervention group reduced 
their consumption by 341 units in the previous month (95 % CI 101-582 units last month). 
There were, however, no statistically significant differences between the hypnotherapy and the 
motivational interviewing groups at follow up. But there was non-significant tendency for the 
hypnotherapy group to have a lower AUDIT score at follow up (p=0.234), so the change in AUDIT 
score was largest for the hypnotherapy group, albeit only on a trend level (p=0.088). This was, 
however, possibly a reflection of the hypnotherapy group’s having the highest portion of the patients 
who reported total abstinence (82 vs. 54 %, p=0.148). There was a strong correlation between 
reporting total abstinence and AUDIT score on follow-up (Spearman’s rho = 0.820, p < 0.001). 
There was somewhat greater, but also far from significant, reduction in mental distress (GSI sum) in 
the hypnotherapy group compared to the control group (mean 0.75 (0.68) vs. 0.46 (SD 0.56); 
p=0.269). 
The analyses at follow up were also done using an intention to treat (ITT) model with last (baseline) 
observation carried forward. There were no differences, even at trend level, between the 
motivational interviewing group and the hypnotherapy group using the ITT model. Furthermore, sub-
group analysis was performed on those who did not have or did have any current or lifetime anxiety 
disorder, depressive disorder or psychotic disorder or any ongoing comorbid mental illness (tab. 1), 
with no statistically significant effect of this subgrouping identified. There was however a trend that 
ongoing anxiety or depressive disorder reduced the difference between motivational interviewing 
and the hypnotherapy intervention groups. 
  
4. Discussion 
In this RCT in the treatment of AUD, patients receiving hypnotherapy did marginally better 
concerning alcohol use at one-year follow-up compared to the controls. The results were not 
statistically significant, but possibly reflected the fact that the portion of the patients reporting total 
abstinence was higher in the hypnotherapy group. There was also a small, although far from 
significant, reduction in mental distress in the hypnotherapy group compared to the control group. 
Regretfully this study had three significant limitations. The first was the small group sizes, rendering 
the study open to type II errors. The second limitation was the study design, which was far from ideal 
to demonstrate and effect of hypnotherapy. Both hypnotherapy and MI were administered as add-
ons, in the context of a substantial treatment program given to all patients. Any specific effect of any 
therapeutic effect would be difficult to establish, considering the amount of time invested in the 
structured program. The third limitation could be that all the treatment in intervention group was 
conducted by one single therapist, the first author of this paper. She has undergone training in 
Erickson’s hypnosis, has practised it for almost ten years and has a personal preference for it. This 
may have influenced the treatment method in the intervention group.  
Nonetheless the above mentioned positive trends could be interpreted in several ways. It could 
indicate that the use of one-hour-a-week hypnotherapy sessions is neither superior nor inferior to 
receiving MI in addition to other therapy for the treatment of AUD. Others have found no significant 
differences between different psychological treatments (Cutler and Fishbain, 2005). Furthermore, a 
meta-analysis had concluded that MI appears to be at least as effective and may possibly be more 
effective than other psychological treatments (Kohler and Hofmann, 2015). Interpreted this way, our 
results may reflect positively on the effectiveness of hypnotherapy. 
The results could, however, indicate that neither hypnotherapy nor MI had any additional effect over 
and above the substantial treatment already given to all patients, and any real effectiveness of these 
two therapeutic interventions was unlikely to be shown because of the set-up of the current study. 
Both intervention and control groups were given only 5 hours of additional individual therapy. Some 
studies indicate that longer duration of counselling gives little additional effect in the treatment of 
AUD (Kaner et al., 2018), but it is not certain whether this applies to hypnotherapy. In some (Potter, 
2004), but not all (Pekala et al., 2004) earlier studies on hypnotherapy in AUD, the number of 
treatments was greater than five. The question of whether additional hours of hypnotherapy could 
have improved the outcome in the hypnotherapy group thus remains unanswered. 
In our study, the size of the groups was small. It is possible that the trend in favour of the 
hypnotherapy group could become statistically significant with an increase in group size. We believe, 
however, that it is important to publish these results, because to date, only two randomized 
controlled trials investigating the use of hypnotherapy on AUD have been conducted (Edwards, 1966, 
Pekala et al., 2004), and our study has a long follow-up time (Pekala et al., 2004). 
Most of the existing psychological treatment methods, such as CBT and MI appeal to reason and 
rational thinking. The patient who seeks treatment, wants to become sober, but emotion may often 
override reason. Hypnotherapy, on the other hand, allows us to address both reason and emotions, 
by reviving previous experiences or creating new in a course of a treatment session. The authors 
believe that this gives hypnotherapy advantage. 
Hypnotherapy is a complex craft that, in experienced hands, can produce immediate and significant 
reduction in mental distress (Barabasz et al., 2013). It is, however, reasonable to assume that for a 
reduction of mental distress to contribute to stable of remission of AUD, such an effect would have to 
last for years. There are some indications that hypnotherapy can give lasting effects, as in the case of 
treatment of headaches (Kohen, 2010). No studies have, however, directly investigated the long-term 
effect of hypnotherapy on anxiety or depression, the two major contributors to mental distress. The 
study by Pekala and co-workers (2004), where AUD was treated with a self-hypnotic intervention, 
describes some lowering of mental distress. This agrees with the results of our study, even if our 
results are not statistically significant.  
In summary, the size of the groups in our RCT on hypnotherapy for AUD was small and the setting was 
far from optimal. At one year follow up there were no statistically significant differences between the 
hypnotherapy group and the motivational interviewing group, but changes in AUDIT score and mental 
distress were largest for the hypnotherapy group. It would be logical to conclude that hypnotherapy 
appears to be at least as effective as MI. Regretfully, because of the set-up of the study, both 
therapeutic interventions functioned as add-ons of an extensive programme. In this setting the real 
effectiveness of MI and hypnotherapy could not be revealed. The authors however believe that 
hypnotherapy might have a potential, meriting further study. 
We would recommend that the future researchers conduct a similar study, comparing two treatments 
without the compounding effects of another intervention, for example, two treatment arms in an 
outpatient clinic. It would be desirable to recruit larger groups and to focus both on the reduction of 
the mental distress and reduction in drinking. 
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Table 1. Baseline characteristics of the motivational interviewing group and the hypnotherapy group  
  Motivational interviewing group Hypnotherapy group  
  (N=15) (N=16) p-value 
Number of women N (%) 1 (7) 3 (19) 0.316a 





(SD) 18.5 (12.4) 15.4 (12.3) 0.491
b 
Any anxiety diagnosis N (%) 10 (67) 10 (63) 0.809a 
Any depression diagnosis N (%) 10 (67) 11 (69) 0.901a 
Any psychosis diagnosis N (%) 3 (20) 2 (13) 0.571a 
Any ongoing diagnosis N (%) 9 (60) 10 (63) 0.886a 
Number of units last month  mean (SD) 291.4 (181.3) 335.6 (75.9) 0.629
b 
AUDIT score (sum) mean (SD) 26.5 (5.4) 28.4 (3.9) 0.270
b 
Mental distress (GSI sum) mean (SD) 1.98 (0.36) 2.06 (0.61) 0.681
b 
aChi-square test, bStudent’s T-test 
 
Table 2. Differences between the control group receiving treatment as usual and the intervention 
group receiving the hypnosis intervention at follow up 1 year after treatment 
  Motivational interviewing group Hypnotherapy group  
  (N=15) (N=16) p-value 
Number at follow up N (%) 13 (87) 11 (69) 0.181a 
Number of women at 
follow up N (%) 0 (0) 3 (19) 0.044
 a 
Number of units last month  mean (SD) 14.2 (21.6) 11.7 (26.1) 0.805
b 
Change in number of units 
last month  
mean 
(SD) 296. 2 (182) 341.5 (358) 0.693
 b 
Total abstinence last 
month N (%) 7 (54) 9 (82) 0.148
 a 
AUDIT score (sum) mean (SD) 7.2 (8.5) 3.4 (6.2) 0.234
 b 
AUDIT score change (sum) mean (SD) 19.5 (8.1) 25.7 (9.1) 0.088
 b 
Mental distress (GSI sum) mean (SD) 1.53 (0.46) 1.40 (0.31) 0.417
 b 
Change in mental distress 
(GSI sum) 
mean 
(SD) 0.46 (0.56) 0.75 (0.68) 0.269
 b 
aChi-square test, bStudent’s T-test 
 
